Late Recurrence After Radiotherapy Omission in Younger Postmenopausal Patients With Breast Cancer: The IDEA Nonrandomized Clinical Trial

Reshma Jagsi; Kent A. Griffith; Eleanor E R Harris; Jean L. Wright; Abram Recht; Alphonse G. Taghian; Brianna M. Jones; Meena S. Moran; William C. Small; Candice Aitken Johnstone; Asal Shoushtari Rahimi; Gary M. Freedman; Mahvish Muzaffar; Bruce George Haffty; Kathleen Claire Horst; Simon N. Powell; Jody Sharp; Michael S. Sabel; Anne F. Schott; Mahmoud Bahij El-Tamer

doi:10.1001/jamaoncol.2026.4529

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

This nonrandomized clinical trial presents updated findings on treatment options for postmenopausal patients with estrogen receptor–positive breast cancer.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Jagsi et al. (2026) studied this question.

synapsesocial.com/papers/6af7fa05a3236dc65aee6454 https://doi.org/10.1001/jamaoncol.2026.4529

View at Publisher

Ask AI

Bookmark

Share

Late Recurrence After Radiotherapy Omission in Younger Postmenopausal Patients With Breast Cancer: The IDEA Nonrandomized Clinical Trial

Ask about this paper

Abstract

Discussion

Cite This Study

Late Recurrence After Radiotherapy Omission in Younger Postmenopausal Patients With Breast Cancer: The IDEA Nonrandomized Clinical Trial

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading